5.1M XNYS Volume
XNYS 28 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 44,155 | 44,155 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Nierenberg Michael | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 252,313 | 252,313 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Zeiden David | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 21,026 | 21,026 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Nicola Santoro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.89 per share. | 21 Feb 2025 | 10,109 | 105,097 (0%) | 0% | 11.9 | 120,196 | Common Stock |
| Michael Nierenberg | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.89 per share. | 21 Feb 2025 | 90,304 | 1,093,220 (0%) | 0% | 11.9 | 1,073,715 | Common Stock |
| Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 1,128 | 114,949 (0%) | 0% | 0 | Common Stock | |
| Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 796 | 37,444 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 1,194 | 56,168 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 19,251 | 905,610 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 6,417 | 301,869 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 7,896 | 1,183,524 (0%) | 0% | 0 | Common Stock | |
| David Zeiden | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 837 | 39,407 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 36,648 | 36,648 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 886,359 | 886,359 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 1,210 | 113,821 (0%) | 0% | 0 | Common Stock | |
| Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 1,280 | 54,974 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 8,470 | 1,175,628 (0%) | 0% | 0 | Common Stock | |
| Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 6,883 | 295,452 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| David Zeiden | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 898 | 38,570 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 1,083 | 112,611 (0%) | 0% | 0 | Common Stock | |
| Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 1,147 | 53,694 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 7,587 | 1,167,158 (0%) | 0% | 0 | Common Stock | |
| Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 6,166 | 288,569 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| David Zeiden | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 804 | 37,672 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Michael Nierenberg | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.15 per share. | 20 Jun 2024 | 106,546 | 1,159,571 (0%) | 0% | 11.2 | 1,187,988 | Common Stock |
| Kevin J. Finnerty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 14,066 | 295,146 (0%) | 0% | 0 | Common Stock | |
| David Saltzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 14,520 | 110,794 (0%) | 0% | 0 | Common Stock | |
| Andrew Sloves | Director | 24 May 2024 | 14,066 | 202,721 (0%) | 0% | 0 | Common Stock | ||
| Peggy Hwan Hebard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 14,520 | 65,124 (0%) | 0% | 0 | Common Stock | |
| Patrice M. Le Melle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 13,612 | 40,846 (0%) | 0% | 0 | Common Stock | |
| Philip M. Sivin | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 325 | 14,927 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Philip M. Sivin | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 216 | 16,431 (0%) | 0% | 0 | Common Stock | |
| Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 1,082 | 111,528 (0%) | 0% | 0 | Common Stock | |
| Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 1,146 | 52,547 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 7,580 | 1,266,117 (0%) | 0% | 0 | Common Stock | |
| Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 6,160 | 282,403 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Michael Nierenberg | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.60 per share. | 21 Mar 2024 | 79,873 | 1,258,537 (0%) | 0% | 10.6 | 846,654 | Common Stock |
| Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 276,243 | 276,243 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Nicola Santoro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.60 per share. | 23 Feb 2024 | 13,427 | 109,414 (0%) | 0% | 10.6 | 142,326 | Common Stock |
| M. Philip Sivin | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.60 per share. | 23 Feb 2024 | 1,957 | 16,009 (0%) | 0% | 10.6 | 20,744 | Common Stock |
| Sivin M. Philip | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 11,682 | 11,682 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 51,401 | 51,401 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Philip M. Sivin | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.60 per share. | 23 Feb 2024 | 1,751 | 16,215 (0%) | 0% | 10.6 | 18,561 | Common Stock |
| Nicola Santoro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.60 per share. | 23 Feb 2024 | 12,395 | 110,446 (0%) | 0% | 10.6 | 131,387 | Common Stock |
| Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 11,341 | 1,338,410 (0%) | 0% | 0 | Common Stock | |
| Santoro Nicola | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 1,620 | 122,841 (0%) | 0% | 0 | Common Stock | |
| Sivin Philip M. | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 323 | 17,966 (0%) | 0% | 0 | Common Stock | |
| Andrew Sloves | Director | 29 Dec 2023 | 12,178 | 168,655 (0%) | 0% | 0 | Common Stock | ||
| Philip M. Sivin | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2023 | 379 | 17,643 (0%) | 0% | 0 | Common Stock | |
| Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2023 | 1,896 | 121,221 (0%) | 0% | 0 | Common Stock | |
| Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2023 | 13,273 | 1,327,069 (0%) | 0% | 0 | Common Stock | |
| Michael Nierenberg | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.30 per share. | 21 Sep 2023 | 106,545 | 1,313,796 (0%) | 0% | 9.3 | 990,869 | Common Stock |
| Philip M. Sivin | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2023 | 332 | 17,264 (0%) | 0% | 0 | Common Stock | |
| Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2023 | 1,663 | 119,325 (0%) | 0% | 0 | Common Stock | |
| Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2023 | 11,642 | 1,420,341 (0%) | 0% | 0 | Common Stock | |
| Kevin J. Finnerty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 18,972 | 281,080 (0%) | 0% | 0 | Common Stock | |
| David Saltzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 19,584 | 96,274 (0%) | 0% | 0 | Common Stock | |
| Andrew Sloves | Director | 26 May 2023 | 18,972 | 156,477 (0%) | 0% | 0 | Common Stock | ||
| Peggy Hwan Hebard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 18,604 | 50,604 (0%) | 0% | 0 | Common Stock | |
| Patrice M. Le Melle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 18,360 | 27,234 (0%) | 0% | 0 | Common Stock | |
| Peggy Hwan Hebard | Director | Grant, award, or other acquisition of securities at price $ 7.94 per share. | 10 May 2023 | 32,000 | 32,000 (0%) | 0% | 7.9 | 254,080 | Common Stock |
| Philip M. Sivin | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 402 | 16,932 (0%) | 0% | 0 | Common Stock | |
| Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 2,011 | 117,662 (0%) | 0% | 0 | Common Stock | |
| Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 14,079 | 1,408,699 (0%) | 0% | 0 | Common Stock | |
| Philip M. Sivin | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 13,130 | 16,530 (0%) | 0% | 0 | Common Stock | |
| Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 65,651 | 115,651 (0%) | 0% | 0 | Common Stock | |
| Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 459,558 | 1,394,620 (0%) | 0% | 0 | Common Stock | |
| Andrew Sloves | Director | 04 Jan 2023 | 15,300 | 137,505 (0%) | 0% | 0 | Common Stock | ||
| Kevin J. Finnerty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 8,048 | 262,108 (0%) | 0% | 0 | Common Stock | |
| Andrew Sloves | Director | 30 Jun 2022 | 8,048 | 122,205 (0%) | 0% | 0 | Common Stock | ||
| Kevin J. Finnerty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 8,874 | 254,060 (0%) | 0% | 0 | Common Stock | |
| Pamela F. Lenehan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 9,761 | 74,953 (0%) | 0% | 0 | Common Stock | |
| Robert J. McGinnis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 8,874 | 128,865 (0%) | 0% | 0 | Common Stock | |
| David Saltzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 8,874 | 76,690 (0%) | 0% | 0 | Common Stock | |
| Andrew Sloves | Director | 27 May 2022 | 8,874 | 114,157 (0%) | 0% | 0 | Common Stock | ||
| Patrice M. Le Melle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 8,874 | 8,874 (0%) | 0% | 0 | Common Stock | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2022 | 340,000 | 340,000 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2022 | 3,567 | 3,567 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2022 | 1,034,500 | 1,034,500 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2022 | 32,000 | 32,000 | - | - | Stock Option (right to buy) | |
| Pamela F. Lenehan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 10,028 | 64,487 (0%) | 0% | 0 | Common Stock | |
| Robert J. McGinnis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 9,116 | 119,991 (0%) | 0% | 0 | Common Stock | |
| Andrew Sloves | Director | 04 Jan 2022 | 9,116 | 105,283 (0%) | 0% | 0 | Common Stock | ||
| Patrice M. Le Melle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2021 | 1,000 | 1,000 | - | - | Stock Option (right to buy) | |
| Robert J. McGinnis | Director | Purchase of securities on an exchange or from another person at price $ 25.18 per share. | 23 Nov 2021 | 4,000 | 4,000 | - | 25.2 | 100,726 | Series D Preferred Shares |
| Douglas L. Jacobs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 9,452 | 57,090 (0%) | 0% | 0 | Common Stock | |
| Kevin J. Finnerty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 9,452 | 270,032 (0%) | 0% | 0 | Common Stock | |
| Pamela F. Lenehan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 10,397 | 54,459 (0%) | 0% | 0 | Common Stock | |
| Robert J. McGinnis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 9,452 | 110,875 (0%) | 0% | 0 | Common Stock | |
| David Saltzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 9,452 | 67,816 (0%) | 0% | 0 | Common Stock | |
| Andrew Sloves | Director | 28 May 2021 | 9,452 | 96,167 (0%) | 0% | 0 | Common Stock | ||
| Michael Nierenberg | Director, Chairman, CEO & President | Purchase of securities on an exchange or from another person at price $ 10.10 per share. | 19 Apr 2021 | 100,000 | 357,028 (0%) | 0% | 10.1 | 1,010,000 | Common Stock |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 1,553 | 1,553 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 394 | 394 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 42,000 | 42,000 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 280,000 | 280,000 | - | - | Stock Option (right to buy) | |
| Kevin J. Finnerty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 10,549 | 260,580 (0%) | 0% | 0 | Common Stock | |
| Pamela F. Lenehan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 10,549 | 42,837 (0%) | 0% | 0 | Common Stock | |
| Alan L. Tyson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 10,549 | 159,707 (0%) | 0% | 0 | Common Stock | |
| Robert J. McGinnis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 10,549 | 101,423 (0%) | 0% | 0 | Common Stock | |
| Andrew Sloves | Director | 04 Jan 2021 | 10,549 | 86,715 (0%) | 0% | 0 | Common Stock | ||
| Alan L. Tyson | None | Purchase of securities on an exchange or from another person at price $ 7.72 per share. | 27 Jul 2020 | 10,000 | 149,158 (0%) | 0% | 7.7 | 77,184 | Common Stock |
| Douglas L. Jacobs | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2020 | 14,766 | 47,638 (0%) | 0% | 0 | Common Stock | |
| Kevin J. Finnerty | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2020 | 13,423 | 250,031 (0%) | 0% | 0 | Common Stock | |
| Pamela F. Lenehan | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2020 | 13,423 | 32,288 (0%) | 0% | 0 | Common Stock | |
| Alan L. Tyson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2020 | 13,423 | 139,158 (0%) | 0% | 0 | Common Stock | |
| Robert J. McGinnis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2020 | 13,423 | 90,874 (0%) | 0% | 0 | Common Stock | |
| David Saltzman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2020 | 13,423 | 58,364 (0%) | 0% | 0 | Common Stock | |
| Andrew Sloves | None | 19 Jun 2020 | 13,423 | 76,166 (0%) | 0% | 0 | Common Stock | ||
| Andrew Sloves | None | 29 May 2020 | 1,200 | 3,700 (0%) | 0% | 7.3 | 8,773 | Common Stock | |
| Andrew Sloves | None | 29 May 2020 | 1,200 | 2,300 (0%) | 0% | 7.3 | 8,747 | Common Stock | |
| Andrew Sloves | None | 29 May 2020 | 1,200 | 3,100 (0%) | 0% | 7.3 | 8,733 | Common Stock | |
| Pamela F. Lenehan | None | Purchase of securities on an exchange or from another person at price $ 5.53 per share. | 19 Mar 2020 | 10,000 | 18,865 (0%) | 0% | 5.5 | 55,310 | Common Stock |
| Andrew Sloves | None | 19 Mar 2020 | 10,000 | 62,743 (0%) | 0% | 6.0 | 60,273 | Common Stock | |
| Alan L. Tyson | None | Purchase of securities on an exchange or from another person at price $ 5.01 per share. | 18 Mar 2020 | 10,000 | 125,735 (0%) | 0% | 5.0 | 50,100 | Common Stock |
| Robert J. McGinnis | None | Purchase of securities on an exchange or from another person at price $ 5.18 per share. | 18 Mar 2020 | 10,000 | 77,451 (0%) | 0% | 5.2 | 51,800 | Common Stock |
| Nicola Santoro | CFO, CAO and Treasurer | Purchase of securities on an exchange or from another person at price $ 5.84 per share. | 18 Mar 2020 | 50,000 | 50,000 (0%) | 0% | 5.8 | 292,000 | Common Stock |
| Andrew Sloves | None | 18 Mar 2020 | 10,000 | 52,743 (0%) | 0% | 5.8 | 58,300 | Common Stock | |
| Andrew Sloves | None | 18 Mar 2020 | 1,000 | 1,000 | - | 11 | 11,000 | Series A Preferred Shares | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2020 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2020 | 26,000 | 26,000 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2020 | 124,200 | 124,200 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2020 | 120,000 | 120,000 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2020 | 800,000 | 800,000 | - | - | Stock Option (right to buy) | |
| Kevin J. Finnerty | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2020 | 6,208 | 236,608 (0%) | 0% | 0 | Common Stock | |
| Pamela F. Lenehan | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2020 | 6,208 | 8,865 (0%) | 0% | 0 | Common Stock | |
| Alan L. Tyson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2020 | 6,208 | 115,735 (0%) | 0% | 0 | Common Stock | |
| Robert J. McGinnis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2020 | 6,208 | 67,451 (0%) | 0% | 0 | Common Stock | |
| Andrew Sloves | None | 02 Jan 2020 | 6,208 | 42,743 (0%) | 0% | 0 | Common Stock | ||
| Andrew Sloves | None | 06 Nov 2019 | 1,000 | 36,535 (0%) | 0% | 15.9 | 15,930 | Common Stock | |
| Robert J. McGinnis | None | Purchase of securities on an exchange or from another person at price $ 15.73 per share. | 30 Oct 2019 | 4,500 | 61,243 (0%) | 0% | 15.7 | 70,777 | Common Stock |
| Michael Nierenberg | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.29 per share. | 31 May 2019 | 400,000 | 1,395,352 (0%) | 0% | 13.3 | 5,316,000 | Common Stock, par value $0.01 per share |
| Michael Nierenberg | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2019 | 400,000 | 0 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.25 per share. | 31 May 2019 | 348,483 | 1,046,869 (0%) | 0% | 15.3 | 5,314,366 | Common Stock, par value $0.01 per share |
| Douglas L. Jacobs | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2019 | 6,659 | 32,872 (0%) | 0% | 0 | Common Stock | |
| Kevin J. Finnerty | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2019 | 6,054 | 230,400 (0%) | 0% | 0 | Common Stock | |
| Pamela F. Lenehan | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2019 | 2,657 | 2,657 (0%) | 0% | 0 | Common Stock | |
| Alan L. Tyson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2019 | 6,054 | 109,527 (0%) | 0% | 0 | Common Stock | |
| Robert J. McGinnis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2019 | 6,054 | 56,743 (0%) | 0% | 0 | Common Stock | |
| David Saltzman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2019 | 6,054 | 44,941 (0%) | 0% | 0 | Common Stock | |
| Andrew Sloves | None | 24 May 2019 | 6,054 | 35,535 (0%) | 0% | 0 | Common Stock | ||
| Andrew Sloves | Director | 14 May 2019 | 400 | 1,900 (0%) | 0% | 16.7 | 6,664 | Common Stock | |
| Andrew Sloves | Director | 14 May 2019 | 400 | 1,100 (0%) | 0% | 16.7 | 6,660 | Common Stock | |
| Andrew Sloves | Director | 14 May 2019 | 1,000 | 2,500 (0%) | 0% | 16.7 | 16,650 | Common Stock | |
| David Saltzman | None | Purchase of securities on an exchange or from another person at price $ 16.66 per share. | 03 May 2019 | 14,174 | 38,887 (0%) | 0% | 16.7 | 236,139 | Common Stock |
| Pamela F. Lenehan | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2019 | 1,000 | 1,000 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2019 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2019 | 2,046 | 2,046 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2019 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2019 | 236 | 236 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2019 | 2,551 | 2,551 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2019 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2019 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2019 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 16.50 per share. | 22 Feb 2019 | 60,000 | 995,352 (0%) | 0% | 16.5 | 990,000 | Common Stock, par value $0.01 per share |
| Kevin J. Finnerty | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 7,038 | 224,346 (0%) | 0% | 0 | Common Stock | |
| Alan L. Tyson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 7,038 | 103,473 (0%) | 0% | 0 | Common Stock | |
| Robert J. McGinnis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 7,038 | 50,689 (0%) | 0% | 0 | Common Stock | |
| Andrew Sloves | None | 02 Jan 2019 | 7,038 | 29,481 (0%) | 0% | 0 | Common Stock | ||
| Michael Nierenberg | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.75 per share. | 26 Jun 2018 | 1,150,000 | 2,085,352 (0%) | 0% | 14.8 | 16,962,500 | Common Stock, par value $0.01 per share |
| Michael Nierenberg | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2018 | 1,150,000 | 0 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2018 | 558,708 | 0 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 18.30 per share. | 26 Jun 2018 | 339,177 | 935,352 (0%) | 0% | 18.3 | 6,206,939 | Common Stock, par value $0.01 per share |
| Michael Nierenberg | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.66 per share. | 26 Jun 2018 | 1,369,531 | 1,274,529 (0%) | 0% | 18.7 | 25,555,448 | Common Stock, par value $0.01 per share |
| Michael Nierenberg | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.38 per share. | 26 Jun 2018 | 558,708 | 2,644,060 (0%) | 0% | 15.4 | 8,592,929 | Common Stock, par value $0.01 per share |
| Douglas L. Jacobs | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2018 | 5,525 | 26,213 (0%) | 0% | 0 | Common Stock | |
| Kevin J. Finnerty | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2018 | 5,525 | 217,308 (0%) | 0% | 0 | Common Stock | |
| Alan L. Tyson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2018 | 5,525 | 96,435 (0%) | 0% | 0 | Common Stock | |
| Robert J. McGinnis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2018 | 5,525 | 43,651 (0%) | 0% | 0 | Common Stock | |
| David Saltzman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2018 | 5,525 | 24,713 (0%) | 0% | 0 | Common Stock | |
| Andrew Sloves | None | 25 May 2018 | 5,525 | 22,443 (0%) | 0% | 0 | Common Stock | ||
| Michael Nierenberg | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2018 | 1,130,916 | 1,130,916 | - | - | Stock Option (right to buy) | |
| Kevin J. Finnerty | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2018 | 4,300 | 211,783 (0%) | 0% | 0 | Common Stock | |
| Alan L. Tyson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2018 | 6,594 | 90,910 (0%) | 0% | 0 | Common Stock | |
| Robert J. McGinnis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2018 | 6,594 | 38,126 (0%) | 0% | 0 | Common Stock | |
| Andrew Sloves | None | 03 Jan 2018 | 6,594 | 16,918 (0%) | 0% | 0 | Common Stock | ||
| Douglas L. Jacobs | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2017 | 4,532 | 20,688 (0%) | 0% | 0 | Common Stock | |
| Kevin J. Finnerty | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2017 | 4,532 | 207,483 (0%) | 0% | 0 | Common Stock | |
| Alan L. Tyson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2017 | 4,532 | 84,316 (0%) | 0% | 0 | Common Stock | |
| Robert J. McGinnis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2017 | 4,532 | 31,532 (0%) | 0% | 0 | Common Stock | |
| David Saltzman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2017 | 4,532 | 19,188 (0%) | 0% | 0 | Common Stock | |
| Andrew Sloves | None | 26 May 2017 | 4,532 | 10,324 (0%) | 0% | 0 | Common Stock | ||
| Michael Nierenberg | Director, Chairman, CEO & President | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 03 Feb 2017 | 2,600 | 935,352 (0%) | 0% | 15 | 39,000 | Common Stock, par value $0.01 per share |
| Michael Nierenberg | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2017 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, Chairman, CEO & President | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 03 Feb 2017 | 8,000 | 24,400 (0%) | 0% | 15 | 120,000 | Common Stock, par value $0.01 per share |
| Michael Nierenberg | Director, Chairman, CEO & President | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 03 Feb 2017 | 8,000 | 23,850 (0%) | 0% | 15 | 120,000 | Common Stock, par value $0.01 per share |
| Andrew Sloves | None | 01 Feb 2017 | 700 | 700 (0%) | 0% | 15.4 | 10,766 | Common Stock | |
| Andrew Sloves | None | 01 Feb 2017 | 500 | 1,500 (0%) | 0% | 15.4 | 7,690 | Common Stock | |
| Andrew Sloves | None | 01 Feb 2017 | 10,000 | 20,000 (0%) | 0% | 15.3 | 153,400 | Common Stock | |
| Kevin J. Finnerty | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2017 | 4,744 | 202,951 (0%) | 0% | 0 | Common Stock | |
| Alan L. Tyson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2017 | 5,377 | 79,784 (0%) | 0% | 0 | Common Stock | |
| Andrew Sloves | None | 03 Jan 2017 | 5,092 | 5,792 (0%) | 0% | 0 | Common Stock | ||
| Robert J. McGinnis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2016 | 1,000 | 1,000 | - | - | Stock Option (right to buy) | |
| Andrew Sloves | None | 11 Nov 2016 | 1,000 | 1,000 | - | - | Common Stock, par value $0.01 per share | ||
| Andrew Sloves | None | 11 Nov 2016 | 10,000 | 10,000 | - | - | Common Stock, par value $0.01 per share | ||
| Andrew Sloves | None | 11 Nov 2016 | 1,500 | 1,500 | - | - | Common Stock, par value $0.01 per share | ||
| Andrew Sloves | None | 11 Nov 2016 | 700 | 700 | - | - | Common Stock, par value $0.01 per share | ||
| Michael Nierenberg | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2016 | 214,285 | 0 | - | - | Stock option (right to buy) | |
| Michael Nierenberg | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2016 | 535,714 | 1,276,060 | - | - | Common Stock, par value $0.01 per share | |
| Michael Nierenberg | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2016 | 535,714 | 0 | - | - | Stock option (right to buy) | |
| Michael Nierenberg | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 31 Aug 2016 | 557,593 | 932,752 | - | - | Common Stock, par value $0.01 per share | |
| Michael Nierenberg | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2016 | 214,285 | 1,490,345 | - | - | Common Stock, par value $0.01 per share | |
| Andrew Sloves | None | 01 Aug 2016 | 2,000 | 2,000 | - | - | Stock Option (right to buy) | ||
| Douglas L. Jacobs | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 5,451 | 14,656 | - | - | Common Stock | |
| Kevin J. Finnerty | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 5,451 | 198,207 | - | - | Common Stock | |
| Alan L. Tyson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 5,451 | 74,407 | - | - | Common Stock | |
| David Saltzman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 5,451 | 14,656 | - | - | Common Stock | |
| Michael Nierenberg | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2016 | 558,708 | 558,708 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2016 | 1,150,000 | 1,150,000 | - | - | Stock Option (right to buy) | |
| Kevin J. Finnerty | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2015 | 6,168 | 192,756 | - | - | Common Stock, par value $0.01 per share | |
| Alan L. Tyson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2015 | 6,168 | 68,956 | - | - | Common Stock, par value $0.01 per share | |
| Wesley R. Edens | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Jun 2015 | 3,245,764 | 518,545 | - | - | Common Stock, par value $0.01 per share | |
| Wesley R. Edens | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2015 | 2,793,538 | 2,793,538 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Jun 2015 | 600 | 15,850 | - | - | Common Stock, par value $0.01 per share | |
| Michael Nierenberg | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Jun 2015 | 7,800 | 740,346 | - | - | Common Stock, par value $0.01 per share | |
| Michael Nierenberg | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Jun 2015 | 700 | 16,400 | - | - | Common Stock, par value $0.01 per share | |
| Wesley R. Edens | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2015 | 849,916 | 0 | - | - | Stock Option (right to buy) | |
| Wesley R. Edens | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2015 | 2,088,928 | 0 | - | - | Stock Option (right to buy) | |
| Wesley R. Edens | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2015 | 909,833 | 3,577,860 | - | - | Common Stock, par value $0.01 per share | |
| Wesley R. Edens | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2015 | 547,583 | 0 | - | - | Stock Option (right to buy) | |
| Wesley R. Edens | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2015 | 1,011,283 | 0 | - | - | Stock Option (right to buy) | |
| Wesley R. Edens | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2015 | 751,983 | 2,668,027 | - | - | Common Stock, par value $0.01 per share | |
| Wesley R. Edens | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Jun 2015 | 2,913,762 | 3,764,309 | - | - | Common Stock, par value $0.01 per share | |
| Wesley R. Edens | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2015 | 909,833 | 0 | - | - | Stock Option (right to buy) | |
| Wesley R. Edens | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2015 | 849,916 | 1,916,044 | - | - | Common Stock, par value $0.01 per share | |
| Wesley R. Edens | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2015 | 2,088,928 | 6,678,071 | - | - | Common Stock, par value $0.01 per share | |
| Wesley R. Edens | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2015 | 751,983 | 0 | - | - | Stock Option (right to buy) | |
| Wesley R. Edens | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2015 | 547,583 | 1,066,128 | - | - | Common Stock, par value $0.01 per share | |
| Wesley R. Edens | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2015 | 1,011,283 | 4,589,143 | - | - | Common Stock, par value $0.01 per share | |
| Douglas L. Jacobs | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2015 | 4,397 | 9,205 | - | - | Common Stock | |
| Kevin J. Finnerty | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2015 | 4,397 | 186,588 | - | - | Common Stock | |
| Alan L. Tyson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2015 | 4,397 | 62,788 | - | - | Common Stock | |
| David Saltzman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2015 | 4,397 | 9,205 | - | - | Common Stock | |
| Alan L. Tyson | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 May 2015 | 20,000 | 58,391 | - | - | Common Stock, par value $0.01 per share | |
| Wesley R. Edens | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2015 | 2,921,302 | 2,921,302 | - | - | Stock Option (right to buy) | |
| Wesley R. Edens | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2015 | 2,828,698 | 2,828,698 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2015 | 258,750 | 258,750 | - | - | Stock Option (rightto buy) | |
| Kevin J. Finnerty | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2015 | 4,868 | 182,191 | - | - | Common Stock, par value $0.01 per share | |
| Alan L. Tyson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2015 | 4,868 | 38,391 | - | - | Common Stock, par value $0.01 per share | |
| Alan L. Tyson | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2014 | 2,000 | 0 | - | - | Stock Option (right to buy) | |
| Alan L. Tyson | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2014 | 2,000 | 67,916 | - | - | Common Stock, par value $0.01 per share | |
| Alan L. Tyson | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 27 Aug 2014 | 870 | 67,046 | - | - | Common Stock, par value $0.01 per share | |
| Wesley R. Edens | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 22 Aug 2014 | 134,800 | 0 | - | - | Common Stock | |
| Wesley R. Edens | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 22 Aug 2014 | 56,800 | 0 | - | - | Common Stock | |
| Michael Nierenberg | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Aug 2014 | 13,246 | 513,496 | - | - | Common Stock, par value $0.01 per share | |
| Michael Nierenberg | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Aug 2014 | 219,050 | 732,546 | - | - | Common Stock, par value $0.01 per share | |
| Michael Nierenberg | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Aug 2014 | 15,700 | 15,700 | - | - | Common Stock, par value $0.01 per share | |
| Michael Nierenberg | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Aug 2014 | 15,250 | 15,250 | - | - | Common Stock, par value $0.01 per share | |
| Douglas L. Jacobs | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2014 | 9,616 | 9,616 | - | - | Common Stock | |
| Kevin J. Finnerty | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2014 | 9,616 | 354,646 | - | - | Common Stock | |
| Alan L. Tyson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2014 | 9,616 | 65,916 | - | - | Common Stock | |
| David Saltzman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2014 | 9,616 | 9,616 | - | - | Common Stock | |
| Wesley R. Edens | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2014 | 2,875,000 | 2,875,000 | - | - | Stock Option (right to buy) | |
| Michael Nierenberg | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Apr 2014 | 1,000,000 | 1,000,500 | - | - | Common Stock, par value $0.01 per share | |
| Kevin J. Finnerty | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2014 | 11,695 | 320,680 | - | - | Common Stock | |
| Alan L. Tyson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2013 | 11,695 | 56,300 | - | - | Common Stock | |
| Douglas L. Jacobs | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2013 | 2,000 | 2,000 | - | - | Stock Option (right to buy) | |
| Kevin J. Finnerty | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2013 | 2,000 | 2,000 | - | - | Stock Option (right to buy) | |
| Alan L. Tyson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2013 | 2,000 | 2,000 | - | - | Stock Option (right to buy) | |
| David Saltzman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2013 | 2,000 | 2,000 | - | - | Stock Option (right to buy) | |
| Wesley R. Edens | None | Other type of transaction at price $ 0.00 per share. | 06 May 2013 | 253,025,645 | 0 | - | - | Common Stock | |
| Kenneth M. Riis | Director, CEO and President | Other type of transaction at price $ 0.00 per share. | 06 May 2013 | 253,025,645 | 0 | - | - | Common Stock |